Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2001
Chemotherapy response of breast cancer depends on HER-2 status and anthracycline dose intensity in the neoadjuvant settingT Petit, C Borel, J P Ghnassia, et al.
European Journal of Cancer (Oxford, England : 1990)|January 20, 2004
Comparative value of tumour grade, hormonal receptors, Ki-67, HER-2 and topoisomerase II alpha status as predictive markers in breast cancer patients treated with neoadjuvant anthracycline-based chemotherapyT Petit, M Wilt, M Velten, et al.
Bulletin Du Cancer|November 21, 2000
[Germ-line mutations of the BRCA1 gene in northeastern France]J P Fricker, D Muller, B Cutuli, et al.
Leukemia & Lymphoma|July 1, 1996
Idarubicin and high dose cytarabine: a new salvage treatment for refractory or relapsing non-Hodgkin's lymphomaP Dufour, R Mors, P Berthaud, et al.
Communications Biology|January 22, 2026
MHC1-TIP enables single-tube multimodal immunopeptidome profiling and uncovers intratumoral heterogeneity in antigen presentationMayukha Bathini, Diana Bocaniciu, Fraser D Johnson, et al.
Biorxiv : the Preprint Server for Biology|August 8, 2025
MHC1-TIP enables single-tube multimodal immunopeptidome profiling and uncovers intratumoral heterogeneity in antigen presentationMayukha Bathini, Diana Bocaniciu, Fraser D Johnson, et al.
Pageof 1